Bedrocan
Bedrocan, the sole supplier of medical cannabis products in the Netherlands, has been developing and refining its cultivation and standardisation processes for more than 20 years; and is the only company in the world to produce fully standardised medical cannabis flower with consistent levels of cannabinoid content.
Bedrocan produces standardised cannabis in various formats as an Active Pharmaceutical Ingredient (API) of pharmaceutical quality, to meet the needs of large and small drug developers.
View Cultivation Operations
In the Netherlands, the Office of Medical Cannabis (OMC), part of the Dutch Ministry of Health, is responsible for overseeing the production of cannabis for medicinal and scientific purposes; and Bedrocan is a contract manufacturer of cannabis products for the Dutch government. The OMC distributes Bedrocan cannabis flower to pharmacies, researchers, and pharmaceutical off-takers, both domestically and internationally, as an active pharmaceutical ingredient. Lab testing and packaging are separately contracted with other parties by the OMC. Bedrocan’s responsibility is to cultivate and produce standardised cannabis of pharmaceutical quality. Bedrocan has been the sole supplier of medicinal cannabis in The Netherlands since 2003.
